Sheng Chen

1.9k total citations
49 papers, 1.4k citations indexed

About

Sheng Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Sheng Chen has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 16 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Sheng Chen's work include MicroRNA in disease regulation (10 papers), Extracellular vesicles in disease (10 papers) and Cancer-related molecular mechanisms research (8 papers). Sheng Chen is often cited by papers focused on MicroRNA in disease regulation (10 papers), Extracellular vesicles in disease (10 papers) and Cancer-related molecular mechanisms research (8 papers). Sheng Chen collaborates with scholars based in China, United States and Croatia. Sheng Chen's co-authors include Tingting Ma, Zi Yin, Yu Zhou, Yiping Zou, Jinhai Yan, Lehang Lin, Bowen Huang, Chuanzhao Zhang, Beifang Ning and Xin Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and ACS Applied Materials & Interfaces.

In The Last Decade

Sheng Chen

43 papers receiving 1.4k citations

Peers

Sheng Chen
Lu Qi China
Rohit Mathur United States
Yanmin Xu China
Edward L. LaGory United States
Yu Fan China
Sheng Chen
Citations per year, relative to Sheng Chen Sheng Chen (= 1×) peers Zhengsheng Wu

Countries citing papers authored by Sheng Chen

Since Specialization
Citations

This map shows the geographic impact of Sheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Chen more than expected).

Fields of papers citing papers by Sheng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Chen. The network helps show where Sheng Chen may publish in the future.

Co-authorship network of co-authors of Sheng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Chen. A scholar is included among the top collaborators of Sheng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Chen. Sheng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Sheng, et al.. (2026). Holographic dark energy in a coasting cosmology. Physics Letters B. 874. 140246–140246.
2.
Han, Bing, Hua Zhong, Runbo Zhong, et al.. (2024). 1322P A phase II trial of autologous cytokine-induced killer (CIK) therapy plus toripalimab with or without chemotherapy as first-line treatment in advance NSCLC. Annals of Oncology. 35. S841–S841. 1 indexed citations
3.
Chen, Liping, et al.. (2024). EGFR degraders in non‐small‐cell lung cancer: Breakthrough and unresolved issue. Chemical Biology & Drug Design. 103(4). e14517–e14517. 4 indexed citations
5.
Chen, Sheng, Xiaoling Guan, Junfang Li, et al.. (2023). Magnetically controlled nanorobots induced oriented and rapid clearance of the cytokine storm for acute lung injury therapy. Colloids and Surfaces B Biointerfaces. 234. 113731–113731. 9 indexed citations
7.
Lin, Yinshan, Xiaoling Guan, Sheng Chen, et al.. (2023). Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids Delivery. International Journal of Nanomedicine. Volume 18(1). 8001–8021. 8 indexed citations
8.
Xiong, Wu, Cong Li, Siming Wang, et al.. (2023). Treg cells-derived exosomes promote blood-spinal cord barrier repair and motor function recovery after spinal cord injury by delivering miR-2861. Journal of Nanobiotechnology. 21(1). 364–364. 18 indexed citations
9.
Zhang, Xinzhu, Qiang Zeng, Siming Wang, et al.. (2022). Paclitaxel-incorporated nanoparticles improve functional recovery after spinal cord injury. Frontiers in Pharmacology. 13. 957433–957433. 9 indexed citations
10.
Gu, Jun, Gang Zhao, Jiangkun Yu, et al.. (2022). Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment. Journal of Nanobiotechnology. 20(1). 372–372. 40 indexed citations
11.
Yin, Zi, Yu Zhou, Tingting Ma, et al.. (2020). Down‐regulated lncRNA SBF2‐AS1 in M2 macrophage‐derived exosomes elevates miR‐122‐5p to restrict XIAP, thereby limiting pancreatic cancer development. Journal of Cellular and Molecular Medicine. 24(9). 5028–5038. 102 indexed citations
12.
Zhang, Xiang, et al.. (2020). Hsa_circ_0084927 Regulates Cervical Cancer Advancement via Regulation of the miR-634/TPD52 Axis. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Ding, Jianxun, et al.. (2020). lncRNA CCAT2 Enhanced Resistance of Glioma Cells Against Chemodrugs by Disturbing the Normal Function of miR-424. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Dong, Hongping, Shaojun Liu, Xuejie Zhang, et al.. (2019). An Allosteric PRC2 Inhibitor Targeting EED Suppresses Tumor Progression by Modulating the Immune Response. Cancer Research. 79(21). 5587–5596. 36 indexed citations
15.
Zhang, Ying, Stefan Pusch, Matthew J. Ellis, et al.. (2019). Mutant IDH Sensitizes Gliomas to Endoplasmic Reticulum Stress and Triggers Apoptosis via miR-183-Mediated Inhibition of Semaphorin 3E. Cancer Research. 79(19). 4994–5007. 28 indexed citations
16.
Sun, Yuanyuan, et al.. (2017). miR-198-induced upregulation of Livin may be associated with the prognosis and contribute to the oncogenesis of lung adenocarcinoma. Oncology Reports. 38(4). 2096–2104. 12 indexed citations
17.
Chen, Sheng, Xiaoxiao Qian, Shanshan Huang, et al.. (2016). Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy. Journal of Diabetes and its Complications. 31(3). 569–576. 31 indexed citations
18.
Liu, Jiao, Sheng Chen, Wei Wang, et al.. (2016). Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways. Cancer Letters. 379(1). 49–59. 185 indexed citations
19.
Chen, Sheng, et al.. (2015). MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs. SHILAP Revista de lepidopterología. 14 indexed citations
20.
Hou, Jingyu, et al.. (2012). Clinical Outcomes of Downregulation of E-cadherin Gene Expression in Non-small Cell Lung Cancer. Asian Pacific Journal of Cancer Prevention. 13(4). 1557–1561. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026